A therapist’s experience with MDMA

I’m a Therapist Who Tried MDMA—Here’s How the Experience Shaped My Perspective on Psychedelic Therapy

Sara Reed, licensed marriage and family therapist, tried MDMA therapy as part of MAPS’ training program. Her experience deepened her understanding of herself and helped her process the loss of her grandmother. 

“As the medicine and the music carried me away, my grandmother appeared. Tears flowed down my face and joy filled my heart. It had been years since I had felt her presence like this. Seeing her in this bright, liberating light was an important part of my grieving process.

She took me to a place I knew existed but had never seen. I traveled to what felt like the essence of the universe, a space of Divinity, a place where I belonged. The vision revealed my presence within this enormous Whole—a place that had no beginning or end, where there is no distinction or separation from love. I call that place home. And for the first time in my adult life, I felt freedom. Me, a young Black woman. Free. Human.”

The experience also made Sara realize that the psychedelics industry needs to prioritize culturally sensitive care to make treatments safer and more accessible for BIPOC communities.

PDF of article

Toad venom for Grandma

Biomind Receives Approval for a Third Phase II Clinical Trial for Its 5-MeO-DMT Based BMND08 Candidate for Depression & Anxiety in Alzheimer’s Disease

Could Alzheimer’s patients benefit from one of the most powerful psychedelics? 

Biomind Labs (BMND) will find out in an upcoming study.

The Phase 2 trial, which was just approved by the Argentinian Institutional Review Board, will see if 5-MeO-DMT (a psychedelic found in the venom of the Sonoran Desert toad) can ease depression and anxiety in patients with Alzheimer’s disease.

PDF of article

Canadian Senator microdoses for depression

Canadian Senator Admits He Takes Psilocybin for Depression

In his opening speech at the Catalyst Psychedelics Summit, Canadian Senator Larry Campbell shared his fascinating (yet slightly disturbing) experience with microdosing.

The 74-year-old politician had been suffering from depression and PTSD for ages when his mental health suddenly started improving out of nowhere.

When Larry told his wife the good news, she admitted that she’d been spiking his morning coffee with a bit of psilocybin for the past two weeks 😲

While we don’t condone drugging people without their knowledge, her experiment revealed some important anecdotal evidence – the benefits that Larry experienced must have been from the psilocybin itself and not a result of the placebo effect!

PDF of article

Group ketamine therapy now available for frontline workers

Novamind Launches Group Psychedelic Treatment for Frontline Workers

After piloting the program for 9 months, Novamind’s group ketamine therapy for frontline workers is now available to the public.

The 6-week program is designed to help healthcare workers, police officers, firefighters and paramedics work through trauma with the support of their peers.

“The greatest improvement has been my PTSD… Even when I do feel myself reacting, I feel I have more awareness and I am able to better regulate,” says one of the participants of the pilot program.

PDF of article

3 animals you never knew were psychedelic…

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review

We bet you never knew that these animals could make you trip:

  • Ants: Red harvester ants have been used as a “ritual intoxicant” by at least 7 indigenous Californian groups. Boys and men would swallow hundreds of live ants to induce visions of “dream helpers” to gain shamanic powers. Read more about the ritual here.
  • Sea sponges (yes they are animals): Some species of sea sponges contain two derivatives of DMT: 5-Bromo-DMT and 5,6-dibromo-DMT. 5-Bromo-DMT has been found to have a sedative and antidepressant effect in animal studies.
  • Fish: Many fish are known to be psychedelic. A species called Sarpa salpa can produce vivid auditory and visual hallucinations for 36 hours when ingested. 

The more you know!

PDF of article

Legal psilocybin therapy comes to Quebec

Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment

After several unsuccessful depression treatments, a patient in Quebec will finally get to try psilocybin therapy through the Special Access Program (SAP), marking the first legal psilocybin treatment in the province.

Numinus Wellness (NUMI) received Health Canada approval to administer the treatment at its Montreal clinic. It will be the company’s first treatment outside of a clinical trial setting.

Hopefully we’ll start seeing more wins like this thanks to TheraPsil, a non-profit that launched an initiative to make it easier for patients to access psilocybin through the SAP. 

The initiative, called Project Solace, will secure a safe supply of psilocybin from HAVN Life (HAVN) and other licensed dealers and collect data on treatment outcomes to support policy change. 

PDF of article

Science-backed psychedelic experiences

Leveraging over 20 years of psychedelic research, Beckley Foundation is launching a psilocybin-focused holistic wellbeing company called Beckley Retreats.

Starting this September, Beckley Retreats will offer a self-development program that includes:

  • 4 weeks of virtual preparation
  • A 5-day retreat in Jamaica with 2 psilocybin ceremonies and tons of holistic healing practices
  • 6 weeks of virtual integration to encourage new habits and thought patterns

Led by certified psychotherapists and doctors, the retreat combines Indigenous wisdom with modern science to create an unparalleled experience.

Learn more and reserve your spot here.

Equity initiatives for PTSD treatment

MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD

MAPS announced that its Phase 3 MDMA trial for PTSD is now fully enrolled at 13 sites across the United States and Israel.

The organization took equity initiatives to ensure that BIPOC and LGBTQ+ individuals are represented in the study, as these individuals are more likely to have PTSD (yet less likely to be diagnosed or have reasonable access to treatment).

PDF of article

How to have a safe solo trip

Psilo Psoirée is an online community that allows psychedelic explorers to connect before and after their journeys.

With a monthly membership, you’ll receive:

  • A super informative guide on how to have a safe solo trip
  • Access to monthly pre-journey “lift-off” and post-journey “landing” calls
  • Support on all things mushroom – from navigating a spiritual awakening to DIY mushroom cultivation

Use code DAILYMUSHROOM22 to get a 2-month membership for FREE!

How to avoid adverse reactions to psychedelics

Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and short-lived

A survey of over 9,200 psilocybin mushroom users found that only 0.2% have sought emergency medical treatment following use.

The most common reported reasons for these adverse experiences were:

  • Mixing substances
  • Poor mindset
  • Poor setting

Additionally, those in the emergency care-seeking group were significantly younger than the group that didn’t seek care, with a median age of 19 compared to 23.

Keep this in mind if you’re considering trying psilocybin!

PDF of article